Cardiac dysfunction in patients with end-stage liver disease, prevalence, and impact on outcome: a comparative prospective cohort study

Egyptian Liver Journal

Table 1 Demographic data in patients and controls

	Control group (A)	Patient group (B)	Test value	P value
Gender
Females	17 (42.5%)	22 (55.0%)	5.788	0.055
Males	23 (57.5%)	18 (45.0%)	5.788	0.055
Age
Mean ± SD	51 ± 7	52 ± 7	0.559	0.542
Range	38–62	42–62	0.559	0.542
Cause of cirrhosis
Hepatitis virus C	0 (0%)	26 (65%)	NA	NA
Hepatitis Virus B	0 (0%)	8 (20%)
Cryptogenic	0 (0%)	6 (15%)

0.05 NS non-significant, < 0.05 S significant, < 0.01 HS highly significant, NA not applicable